Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Хроническая обструктивная болезнь легких – проблема женского здоровья
Хроническая обструктивная болезнь легких – проблема женского здоровья
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765–73.
2. Chapman KR, Mannino DM, Soriano JB et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188–207.
3. Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–50.
4. Feenstra TL, van Genugten ML, Hoogenveen RT et al. The impact of ageing and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590–6.
5. Mathers DM, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
6. Mannino DM, Homa DM, Akinbami LJ, Ford ES et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002; 51: 1–16.
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009 (www. goldcopd.com).
8. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176 (6): 532–55.
9. Chen Y, Horne SL, Dustman JA. Increased susceptibility to lung disfunction in female smokers. Am Rev Respir Dis 1991; 143: 1224–30.
10. Langhammer A, Johnsen R, Gulsvik A et al. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21: 1017–23.
11. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994; 7: 477–83.
12. Carter R, Nicotra B, Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest 1994; 106 (6): 1730–9.
13. Han W, Pentecost BT, Pietropaolo RL, Fasco MJ et al. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 2005; 44: 202–11.
14. Капустина В.А., Овчаренко С.И., Литвицкий П.Ф. Влияние длительной антиоксидантной терапии N-ацетилцистеином на показатели оксидативного стресса у больных хронической обструктивной болезнью легких. Фарматека. 2010; 20 (213): 84–49.
15. Watson L, Vestbo J, Postma DS, Decramer M et al. Gender differenses in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98: 1207–03.
16. de Torres JP, Casanova C, Hernandez C, Abreu J et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128: 2012–6.
17. Cydulka RK, Rowe BH, Clark S et al. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005; 12: 1173–9.
18. Di Marco F, Verga M, Reggente M et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006; 100: 1767–74.
19. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? J Obstet Gynecol Neonatal Nurs 1999; 28: 201–8.
20. Decramer M, Celli B, Tashkin DP et al. Clinical Trial Design Considerations in Assessing Long-Term Functional Impacts of Tiotropium in COPD: The Uplift Trial. COPD 2004; 1: 303–12.
21. Lopez Varela MV, Montes de Oca M, Halberrt RJ et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36: 1034–41.
22. Авраменко Л.П., Болотнова Т.В. Клинико-функциональные характеристики хронической обструктивной болезни легких у женщин пожилого возраста. Тезисы XIII Международной научно-практической конференции «Пожилой больной. Качество жизни». Клин. геронтология. 2008; 9 (14): 19.
23. Han MeiLan K, Agusti A, Calverely P et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182 (5): 598–604.
24. Хроническая обструктивная болезнь легких. Под ред. А.Г.Чучалина. M.: Атмосфера, 2008.
25. Martinez FJ, Curtis JL, Sciurba F et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243–52.
26. Овчаренко С.И., Капустина В.А. Хроническая обструктивная болезнь легких: особенности у женщин. Пульмонология. 2009; 2: 102–12.
27. Vestbo J, Anderson W, Coxson HO et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-point (ECLIPSE). Eur Respir J 2008; 31: 869–73.
28. Agusti A, Calverely P, Celli B et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Research 2010; 11: 122.
2. Chapman KR, Mannino DM, Soriano JB et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188–207.
3. Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741–50.
4. Feenstra TL, van Genugten ML, Hoogenveen RT et al. The impact of ageing and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med 2001; 164: 590–6.
5. Mathers DM, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
6. Mannino DM, Homa DM, Akinbami LJ, Ford ES et al. Chronic obstructive pulmonary disease surveillance: United States, 1971–2000. MMWR Surveill Summ 2002; 51: 1–16.
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2009 (www. goldcopd.com).
8. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176 (6): 532–55.
9. Chen Y, Horne SL, Dustman JA. Increased susceptibility to lung disfunction in female smokers. Am Rev Respir Dis 1991; 143: 1224–30.
10. Langhammer A, Johnsen R, Gulsvik A et al. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21: 1017–23.
11. Xu X, Li B, Wang L. Gender difference in smoking effects on adult pulmonary function. Eur Respir J 1994; 7: 477–83.
12. Carter R, Nicotra B, Huber G. Differing effects of airway obstruction on physical work capacity and ventilation in men and women with COPD. Chest 1994; 106 (6): 1730–9.
13. Han W, Pentecost BT, Pietropaolo RL, Fasco MJ et al. Estrogen receptor alpha increases basal and cigarette smoke extract-induced expression of CYP1A1 and CYP1B1, but not GSTP1, in normal human bronchial epithelial cells. Mol Carcinog 2005; 44: 202–11.
14. Капустина В.А., Овчаренко С.И., Литвицкий П.Ф. Влияние длительной антиоксидантной терапии N-ацетилцистеином на показатели оксидативного стресса у больных хронической обструктивной болезнью легких. Фарматека. 2010; 20 (213): 84–49.
15. Watson L, Vestbo J, Postma DS, Decramer M et al. Gender differenses in the management and experience of chronic obstructive pulmonary disease. Respir Med 2004; 98: 1207–03.
16. de Torres JP, Casanova C, Hernandez C, Abreu J et al. Gender and COPD in patients attending a pulmonary clinic. Chest 2005; 128: 2012–6.
17. Cydulka RK, Rowe BH, Clark S et al. Gender differences in emergency department patients with chronic obstructive pulmonary disease exacerbations. Acad Emerg Med 2005; 12: 1173–9.
18. Di Marco F, Verga M, Reggente M et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med 2006; 100: 1767–74.
19. Gift AG, Shepard CE. Fatigue and other symptoms in patients with chronic obstructive pulmonary disease: do women and men differ? J Obstet Gynecol Neonatal Nurs 1999; 28: 201–8.
20. Decramer M, Celli B, Tashkin DP et al. Clinical Trial Design Considerations in Assessing Long-Term Functional Impacts of Tiotropium in COPD: The Uplift Trial. COPD 2004; 1: 303–12.
21. Lopez Varela MV, Montes de Oca M, Halberrt RJ et al. Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010; 36: 1034–41.
22. Авраменко Л.П., Болотнова Т.В. Клинико-функциональные характеристики хронической обструктивной болезни легких у женщин пожилого возраста. Тезисы XIII Международной научно-практической конференции «Пожилой больной. Качество жизни». Клин. геронтология. 2008; 9 (14): 19.
23. Han MeiLan K, Agusti A, Calverely P et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182 (5): 598–604.
24. Хроническая обструктивная болезнь легких. Под ред. А.Г.Чучалина. M.: Атмосфера, 2008.
25. Martinez FJ, Curtis JL, Sciurba F et al. Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med 2007; 176: 243–52.
26. Овчаренко С.И., Капустина В.А. Хроническая обструктивная болезнь легких: особенности у женщин. Пульмонология. 2009; 2: 102–12.
27. Vestbo J, Anderson W, Coxson HO et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-point (ECLIPSE). Eur Respir J 2008; 31: 869–73.
28. Agusti A, Calverely P, Celli B et al. Characterization of COPD heterogeneity in the ECLIPSE cohort. Respir Research 2010; 11: 122.
Авторы
С.И.Овчаренко, В.А.Капустина
Кафедра факультетской терапии №1 лечебного факультета ГОУ ВПО Первого МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Кафедра факультетской терапии №1 лечебного факультета ГОУ ВПО Первого МГМУ им. И.М.Сеченова Минздравсоцразвития РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.